J. Stocker

Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndrome.

E. Kohn, E. Sausville, D. Longo, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I trial of dihydrolenperone in lung cancer patients: A novel compound within vitro activity against lung cancer

R. Shoemaker, A. Gazdar, J. Mulshine, 1993, Investigational New Drugs.

A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides.

S. Steinberg, E. Sausville, F. Kaye, 1989, The New England journal of medicine.

Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome.

S. Steinberg, I. Linnoila, F. Foss, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic implications of evaluation for lymph node involvement by T- cell antigen receptor gene rearrangement in mycosis fungoides

S. Steinberg, E. Sausville, E. Sausville, 1992 .

Prognostic implications of evaluation for lymph node involvement by T-cell antigen receptor gene rearrangement in mycosis fungoides.

S. Steinberg, E. Sausville, A. Fischmann, 1992, Blood.

A randomized phase II trial of two different schedules of mitomycin C and vinorelbine in pretreated breast cancer.

M. Colleoni, G. Vicario, C. Graiff, 1997, Oncology.